Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease

This publication has 21 references indexed in Scilit:

• Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
  Gastroenterology, 2000
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
  New England Journal of Medicine, 1997
• Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group
  Gastroenterology, 1997
• The basis of current and future therapy for inflammatory bowel disease
  The American Journal of Medicine, 1996
• Interleukin-10 gene knock-out mice: a model of chronic inflammation
  Clinical Immunology and Immunopathology, 1995
• T cells in inflammatory bowel disease: protective and pathogenic roles
  Immunity, 1995
• Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
  Gastroenterology, 1995
• Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
  Published by Elsevier ,1994
• Interleukin-10-deficient mice develop chronic enterocolitis
  Cell, 1993
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
  The Journal of Experimental Medicine, 1989